MX2009009701A - Agente preventivo y/o terapeutico novedoso para neuropatia diabetica. - Google Patents
Agente preventivo y/o terapeutico novedoso para neuropatia diabetica.Info
- Publication number
- MX2009009701A MX2009009701A MX2009009701A MX2009009701A MX2009009701A MX 2009009701 A MX2009009701 A MX 2009009701A MX 2009009701 A MX2009009701 A MX 2009009701A MX 2009009701 A MX2009009701 A MX 2009009701A MX 2009009701 A MX2009009701 A MX 2009009701A
- Authority
- MX
- Mexico
- Prior art keywords
- diabetic
- therapeutic agent
- prophylactic
- nerve disorder
- abnormal
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
- C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Diabetes (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Abstract
Se describe un agente profiláctico y/o terapéutico excelente para neuropatía diabética, el cual comprende 2- [(indeno-7-iloxi substituido)metil]morfolina representado por la fórmula (I) o una sal farmacéuticamente aceptable del mismo como un ingrediente activo. El agente profiláctico y/o terapéutico es particularmente útil como un agente profiláctico y/o terapéutico para trastorno de nervio motor diabético (por ejemplo, disminución en fuerza muscular (disminución en fuerza muscular hasta un grado de ser incapaz de caminar independientemente)), trastorno de nervio sensorial diabético (parestesia (sensación de vibración anormal), alodinia, sensación reducida (entumecimiento de extremidades, psicroestesia) o dolor), o trastorno de nervio autónomo diabético (por ejemplo, habituación anormal del intestino, tal como constipación y diarrea, disfunción urinaria, impotencia, hipotensión ortoestática, dishidrosis, variabilidad anormal en frecuencia cardíaca, vaciamiento gástrico retardado). También se describe un agente de disminución de una condición de enfermedad de un trastorno de nervio diabético.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2007066727 | 2007-03-15 | ||
JP2007242210 | 2007-09-19 | ||
PCT/JP2008/054710 WO2008111669A1 (ja) | 2007-03-15 | 2008-03-14 | 糖尿病性神経障害の新規予防剤及び/又は治療剤 |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2009009701A true MX2009009701A (es) | 2009-10-07 |
Family
ID=39759597
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2009009701A MX2009009701A (es) | 2007-03-15 | 2008-03-14 | Agente preventivo y/o terapeutico novedoso para neuropatia diabetica. |
Country Status (12)
Country | Link |
---|---|
US (2) | US20100113451A1 (es) |
EP (1) | EP2123643A4 (es) |
JP (1) | JP5278308B2 (es) |
KR (1) | KR20090130052A (es) |
AU (1) | AU2008225379A1 (es) |
BR (1) | BRPI0808806A2 (es) |
CA (1) | CA2680938A1 (es) |
IL (1) | IL200669A0 (es) |
MX (1) | MX2009009701A (es) |
RU (1) | RU2465906C2 (es) |
TW (1) | TW200846003A (es) |
WO (1) | WO2008111669A1 (es) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2736560A1 (en) | 2008-09-11 | 2010-03-18 | Astellas Pharma Inc. | Novel salt of morpholine derivative |
EP2329824A4 (en) | 2008-09-11 | 2013-01-16 | Astellas Pharma Inc | NEW PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF NOZIZEPTIVE PAIN |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4109088A (en) * | 1975-01-29 | 1978-08-22 | Yamanouchi Pharmaceutical Co., Ltd. | 2-(indenyloxymethyl) morpholine derivatives |
JPS52111580A (en) * | 1976-03-15 | 1977-09-19 | Yamanouchi Pharmaceut Co Ltd | Novel indene derivatives and salts thereof |
AU670675B2 (en) * | 1993-02-10 | 1996-07-25 | Yamanouchi Pharmaceutical Co., Ltd. | Morpholine derivative |
EP1113797B1 (en) * | 1998-09-15 | 2009-11-25 | Eli Lilly And Company | Use of duloxetine for the treatment of fibromyalgia |
US6380200B1 (en) * | 1999-12-07 | 2002-04-30 | Pfizer, Inc. | Combination of aldose reductase inhibitors and selective serotonin reuptake inhibitors for the treatment of diabetic complications |
US20070042969A1 (en) * | 2004-03-26 | 2007-02-22 | Srz Properties, Inc. | Combination therapy for pain in painful diabetic neuropathy |
WO2005105763A1 (en) * | 2004-04-30 | 2005-11-10 | Warner-Lambert Company Llc | Substituted morpholine compounds for the treatment of central nervous system disorders |
EP1767217A1 (en) * | 2004-07-14 | 2007-03-28 | Astellas Pharma Inc. | Agent for promoting the recovery from dysfunction after the onset of central neurological disease |
CA2607219A1 (en) * | 2005-05-18 | 2007-02-15 | Neuraxon, Inc. | Substituted benzimidazole compounds with dual nos inhibitory activity and mu opioid agonist activity |
EA200802412A1 (ru) * | 2006-06-08 | 2009-06-30 | Шварц Фарма Аг | Терапевтические комбинации для сопровождающихся болью медицинских состояний |
-
2008
- 2008-03-13 TW TW097108876A patent/TW200846003A/zh unknown
- 2008-03-14 EP EP08722106A patent/EP2123643A4/en not_active Withdrawn
- 2008-03-14 CA CA002680938A patent/CA2680938A1/en not_active Abandoned
- 2008-03-14 US US12/530,745 patent/US20100113451A1/en not_active Abandoned
- 2008-03-14 MX MX2009009701A patent/MX2009009701A/es not_active Application Discontinuation
- 2008-03-14 KR KR1020097021416A patent/KR20090130052A/ko not_active Application Discontinuation
- 2008-03-14 WO PCT/JP2008/054710 patent/WO2008111669A1/ja active Application Filing
- 2008-03-14 BR BRPI0808806-3A patent/BRPI0808806A2/pt not_active IP Right Cessation
- 2008-03-14 AU AU2008225379A patent/AU2008225379A1/en not_active Abandoned
- 2008-03-14 JP JP2009504092A patent/JP5278308B2/ja not_active Expired - Fee Related
- 2008-03-14 RU RU2009138032/15A patent/RU2465906C2/ru not_active IP Right Cessation
-
2009
- 2009-09-01 IL IL200669A patent/IL200669A0/en unknown
-
2012
- 2012-08-23 US US13/592,544 patent/US20130023535A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP2123643A1 (en) | 2009-11-25 |
CA2680938A1 (en) | 2008-09-18 |
WO2008111669A1 (ja) | 2008-09-18 |
EP2123643A4 (en) | 2011-12-07 |
BRPI0808806A2 (pt) | 2014-08-19 |
TW200846003A (en) | 2008-12-01 |
US20100113451A1 (en) | 2010-05-06 |
RU2465906C2 (ru) | 2012-11-10 |
US20130023535A1 (en) | 2013-01-24 |
AU2008225379A1 (en) | 2008-09-18 |
IL200669A0 (en) | 2010-05-17 |
KR20090130052A (ko) | 2009-12-17 |
JPWO2008111669A1 (ja) | 2010-06-24 |
JP5278308B2 (ja) | 2013-09-04 |
RU2009138032A (ru) | 2011-04-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MY145439A (en) | Use of flibanserin for the treatment of pre-menopausal sexual desire disorders | |
WO2012005500A3 (ko) | 다폭세틴을 포함하는 시간차 서방출 경구투여형 약학적 조성물 | |
TW200609227A (en) | Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 | |
NZ589445A (en) | Rasagiline for parkinson's disease modification | |
SG153830A1 (en) | Galenic formulations of organic compounds | |
FR12C0052I1 (es) | ||
WO2014146082A1 (en) | Materials and methods for treating neuropathies and related disorders including those involving a keystone nerve | |
MXPA06013133A (es) | Formulaciones farmaceuticas y usos de las mismas en el tratamiento de la disfuncion sexual femenina. | |
MX369959B (es) | Composicion de farmaco conjugado. | |
SI1891038T1 (sl) | Substituirani n-arilpirolodini kot selektivni modulatorji androgenskega receptorja | |
HRP20140280T1 (hr) | Uporaba 1-fenil-3-dimetilamino-propan spojeva u terapiji neuropatske boli | |
RU2012145116A (ru) | Фармацевтическая композиция для предупреждения или лечения неалкогольного жирового гепатоза и способ предупреждения или лечения неалкогольного жирового гепатоза с ее использованием | |
WO2005056524A3 (en) | Therapeutic agents useful for treating pain | |
WO2008060332A8 (en) | Methods for treating or reducing muscle fatigue | |
MX2012001160A (es) | Agonistas del receptor de esfingosina-1-fosfato. | |
EA200801310A1 (ru) | Фармацевтические препараты и их применение при лечении половой дисфункции у женщин | |
MX2009009701A (es) | Agente preventivo y/o terapeutico novedoso para neuropatia diabetica. | |
CA2262268C (en) | Method of treating impotence due to spinal cord injury | |
EA200700178A1 (ru) | Пептид, обладающий стресспротекторным действием, фармацевтическая композиция на его основе и способ ее применения | |
WO2010022326A3 (en) | Transdermal delivery of apomorphine using microneedles | |
TW200621231A (en) | Therapeutic combinations comprising a selective estrogen receptor modulator and a selective androgen receptor modulator | |
MX2009006634A (es) | Compuestos de imidazolidinonil aminopirimidina para el tratamiento de cancer. | |
WO2008099804A1 (ja) | 糖尿病白内障の治療剤 | |
WO2007139433A8 (en) | Peptide substance normalizing the metabolism in osseous and cartilaginous tissues, pharmaceutical composition on its base and the method of its application | |
NZ595798A (en) | Ectoparasiticidal methods and formulations |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |